239 related articles for article (PubMed ID: 28682795)
1. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
[TBL] [Abstract][Full Text] [Related]
2. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
3. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
[TBL] [Abstract][Full Text] [Related]
4. Can we move towards personalised pancreatic cancer therapy?
Jamieson NB; Chang DK; Grimmond SM; Biankin AV
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):335-8. PubMed ID: 24702631
[No Abstract] [Full Text] [Related]
5. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Thompson ED; Roberts NJ; Wood LD; Eshleman JR; Goggins MG; Kern SE; Klein AP; Hruban RH
Mod Pathol; 2020 Dec; 33(12):2544-2563. PubMed ID: 32704031
[TBL] [Abstract][Full Text] [Related]
6. Genetics of Familial and Sporadic Pancreatic Cancer.
Wood LD; Yurgelun MB; Goggins MG
Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.
Magee CJ; Greenhalf W; Howes N; Ghaneh P; Neoptolemos JP
Surg Oncol; 2001; 10(1-2):1-23. PubMed ID: 11719025
[TBL] [Abstract][Full Text] [Related]
8. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
Theisen BK; Wald AI; Singhi AD
Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
Connor AA; Gallinger S
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572
[TBL] [Abstract][Full Text] [Related]
10. Molecular landscape of pancreatic cancer: challenges and clinical implications.
Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
[No Abstract] [Full Text] [Related]
11. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
Malla RR; Kumari S
Crit Rev Oncog; 2019; 24(2):119-132. PubMed ID: 31679207
[TBL] [Abstract][Full Text] [Related]
13. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic biomarkers: could they be the answer?
Lamarca A; Feliu J
World J Gastroenterol; 2014 Jun; 20(24):7819-29. PubMed ID: 24976720
[TBL] [Abstract][Full Text] [Related]
15. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
[TBL] [Abstract][Full Text] [Related]
16. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Ho J; Li X; Zhang L; Liang Y; Hu W; Yau JCW; Chan H; Gin T; Chan MTV; Tse G; Wu WKK
Semin Cancer Biol; 2019 Apr; 55():70-77. PubMed ID: 29705685
[TBL] [Abstract][Full Text] [Related]
17. Organoid models for translational pancreatic cancer research.
Tiriac H; Plenker D; Baker LA; Tuveson DA
Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer development and progression: remodeling the model.
Real FX; Cibrián-Uhalte E; Martinelli P
Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
[No Abstract] [Full Text] [Related]
20. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.
Hessmann E; Schneider G; Ellenrieder V; Siveke JT
Oncogene; 2016 Mar; 35(13):1609-18. PubMed ID: 26119937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]